iBio, Inc. Stock Forecast

Stock Price Forecast

According to 8 analysts polled by S&P Global, iBio, Inc. stock has a consensus rating of "Strong Buy" and an average price target of $5.53. The average 1-year stock price forecast is 227.22% higher than the current stock price, while the lowest is $4.20 (+148.52%) and the highest is $7.00 (+314.20%).

Price Target: $5.53 (+227.22%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$4.20	$5.53	$5.50	$7.00
Change	+148.52%	+227.22%	+225.44%	+314.20%

Analyst Ratings

The average analyst rating for iBio, Inc. stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	5	5	6	6	6	7
Buy	0	0	0	0	0	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	6	6	6	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Martin Auster Raymond James	Raymond James	Buy Initiates $5	Buy	Initiates	$5	+195.86%	Jun 8, 2026
Patrick Dolezal LifeSci Capital	LifeSci Capital	Buy Maintains $5	Buy	Maintains	$5	+195.86%	May 16, 2026
Roanna Ruiz Leerink Partners	Leerink Partners	Buy Maintains $5 → $6	Buy	Maintains	$5 → $6	+255.03%	May 15, 2026
Unknown Analyst Oppenheimer No rating	Oppenheimer	Buy Maintains $6	Buy	Maintains	$6	+255.03%	May 14, 2026
Keay Nakae Chardan Capital	Chardan Capital	Buy Reiterates $5	Buy	Reiterates	$5	+195.86%	May 14, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

157.14K

from 400.00K

-60.72%

from 400.00K

Revenue Next Year

85.71K

from 157.14K

-45.46%

from 157.14K

EPS This Year

-0.33

from -1.75

EPS Next Year

-0.31

from -0.33

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026
Revenue	2.37M	1.88M	-	225.00K	400.00K	157.14K
Revenue Growth	44.75%	-20.54%	-	-	77.78%	-60.72%
Operating Income	-30.97M	-29.70M	-28.78M	-16.63M	-18.60M	-32.80M
Net Income	-23.21M	-50.30M	-65.01M	-24.91M	-18.38M	-30.27M
EPS	-	-	-	-	-1.75	-0.33
Free Cash Flow	-22.03M	-26.63M	-30.52M	8.36M	-6.65M	-29.00M
No. Analysts	-	-	-	-	-	7

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	500,000
Avg	157,140
Low	100,000

Revenue Growth

Revenue Growth	2026	2027	2028
High	25.0%
Avg	-60.7%
Low	-75.0%

EPS Forecast

EPS	2026	2027	2028
High	-0.25
Avg	-0.33
Low	-0.47

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-